Amikacin sulfate is an aminoglycoside antibiotic that has a good effect on most Enterobacteriaceae, Pseudomonas aeruginosa and some other Pseudomonas, Acinetobacter, Alcaligenes, etc. It also has a good antibacterial effect on meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. Its antibacterial activity is slightly lower than that of gentamicin. The most prominent advantage of this product is that it is stable against aminoglycoside deactivating enzymes produced by many intestinal Gram-negative bacteria and will not lose its antibacterial activity due to deactivation of such enzymes. The mechanism of action is to act on the 30S subunit of the bacterial ribosome and inhibit bacterial protein synthesis. Amikacin can often achieve a synergistic antibacterial effect when used in combination with semi-synthetic penicillins or cephalosporins.

Amikacin sulfate is an aminoglycoside antibiotic that has good antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa and some other Pseudomonas, Acinetobacter, Alcaligenes, etc. It also has good antibacterial effects on meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. Its antibacterial activity is slightly lower than that of gentamicin. Its most prominent advantage is that it is stable against aminoglycoside inactivating enzymes produced by many intestinal Gram-negative bacteria and will not lose its antibacterial activity due to inactivation of such enzymes. The mechanism of action is to act on the 30S subunit of bacterial ribosomes and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often achieves synergistic antibacterial effects.

This product is a new type of antipsychotic drug, which is an antagonist of multiple neurotransmitter receptors in the brain. Its antipsychotic mechanism may be mainly to block central dopamine D2 receptors and 5-HT2 receptors. It also has a blocking effect on histamine H1 and adrenaline (1 receptors, and has no affinity for muscarinic and benzodiazepine receptors.

This product is a new type of antipsychotic drug, which is an antagonist of multiple neurotransmitter receptors in the brain. Its antipsychotic mechanism may be mainly to block central dopamine D2 receptors and 5-HT2 receptors. It also has a blocking effect on histamine H1 and adrenaline (1 receptors, and has no affinity for muscarinic and benzodiazepine receptors.

Not yet clear